Free Trial

Editas Medicine (EDIT) SEC Filings & 10K Form

Editas Medicine logo
$1.03 -0.09 (-8.04%)
Closing price 04:00 PM Eastern
Extended Trading
$1.06 +0.02 (+2.43%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Editas Medicine SEC Filings

DateFilerForm TypeView
03/27/2025
3:41 PM
Editas Medicine (Issuer)
Lucera Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
3:33 PM
Burkly Linda (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
3:37 PM
Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2025
11:15 PM
Editas Medicine (Filer)
Form EFFECT
03/20/2025
3:30 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:10 PM
Editas Medicine (Filer)
Form POS AM
03/05/2025
3:43 PM
Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:44 PM
Editas Medicine (Issuer)
Lucera Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:06 PM
Editas Medicine (Filer)
Form POSASR
02/28/2025
3:35 PM
Burkly Linda (Reporting)
Editas Medicine (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
7:45 AM
Deep Track Capital, LP (Filed by)
Editas Medicine (Subject)
Form SCHEDULE 13G/A
01/13/2025
8:03 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
3:17 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:37 PM
Editas Medicine (Issuer)
Mei Baisong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:40 PM
Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
1:30 PM
Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:57 AM
Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:36 AM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
6:33 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
6:04 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
12:10 PM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/06/2024
3:18 PM
Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:20 PM
Editas Medicine (Issuer)
Mei Baisong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
6:06 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
4:02 PM
Burkly Linda (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
4:01 PM
Editas Medicine (Issuer)
Mei Baisong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
6:23 PM
Editas Medicine (Subject)
Mei Baisong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/18/2024
3:17 PM
Burkly Linda (Reporting)
Editas Medicine (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
5:28 AM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/27/2024
4:02 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:04 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
4:11 PM
Editas Medicine (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:13 PM
Chatterjee Meeta (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:14 PM
Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:15 PM
Editas Medicine (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:30 PM
Editas Medicine (Issuer)
Reeve Emma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:30 PM
Editas Medicine (Issuer)
Lucera Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:32 PM
Editas Medicine (Subject)
Lucera Erick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:17 PM
Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:21 PM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:08 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
04/16/2024
3:30 PM
Editas Medicine (Filer)
Form DEFA14A
04/16/2024
3:25 PM
Editas Medicine (Filer)
Form DEF 14A
04/10/2024
8:37 AM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:EDIT) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners